VR Logo

Unrated

SBI Healthcare Opportunities Fund


1 Lakh

Investment Grown to
₹ 2.06 Lakh

₹ 10000

Monthly SIP Grown to
₹ 6.16 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 17.34 1.09 2.02 3.41 18.08 20.66 59.88 27.16 11.41 15.83 17.60
S&P BSE Healthcare TRI 17.69 0.86 2.88 3.83 18.91 21.35 59.57 24.46 11.99 13.92 15.71
Equity: Sectoral-Pharma 14.64 0.81 2.31 3.18 16.89 18.42 55.47 27.48 14.20 16.43 16.81
Rank within category 2 3 8 4 2 3 2 2 4 2 2
Number of funds in category 10 12 12 10 10 10 9 4 4 3 3

As on 11-Jun-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 59.88 27.16 11.41 2.27 1,899
Nippon India Pharma Fund
Unrated
Jun-04 58.32 29.84 18.26 2.04 5,238
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 59.53 -- -- 2.19 2,683
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 57.98 -- -- 2.13 1,595
DSP Healthcare Fund - Regular Plan  | Invest Online
Unrated
Nov-18 60.09 -- -- 2.40 1,311

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 19.09 01-Apr-2020 - 09-Apr-2020 -21.04 20-Oct-2008 - 27-Oct-2008
Month 35.97 05-May-2009 - 04-Jun-2009 -33.77 01-Oct-2008 - 31-Oct-2008
Quarter 74.69 12-Mar-2009 - 11-Jun-2009 -44.39 02-Sep-2008 - 02-Dec-2008
Year 162.88 07-May-2003 - 06-May-2004 -51.81 12-Mar-2008 - 12-Mar-2009

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 25.36 20.64 1.02 1.95 0.87 3.52
S&P BSE Healthcare TRI 24.50 23.02 0.88 1.97 -- --
Equity: Sectoral-Pharma 26.11 20.35 1.07 2.36 0.86 4.43
Rank within category 4 3 3 4 2 3
Number of funds in category 4 4 4 4 4 4

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-May-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 23
Top 10 Stocks (%) 68.42
Top 5 Stocks (%) 46.65
Top 3 Sectors (%) 96.72
Portfolio P/B Ratio 4.40
Portfolio P/E Ratio 30.93

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 42,142 52,129
Giant (%) 10.22 12.96
Large (%) 55.69 54.17
Mid (%) 19.85 25.62
Small (%) 14.24 8.70
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Dr. Reddy's Lab Healthcare 46.46 10.86 0.00 10.07
up Sun Pharmaceutical Inds. Healthcare 56.29 14.48 4.95 9.85
up Aurobindo Pharma Healthcare 11.10 11.32 0.00 9.25
equal Cipla Healthcare 32.45 10.25 2.05 9.00
down Lupin Healthcare 45.89 10.14 0.00 8.48
equal Divi's Laboratories Healthcare 58.00 10.72 5.42 7.95
up Alkem Laboratories Healthcare 24.11 6.48 0.00 3.94
equal Narayana Hrudayalaya Healthcare -- 4.60 0.00 3.46
equal Cadila Healthcare Healthcare 31.91 5.20 0.00 3.26
equal Max Healthcare Institute Healthcare -- 3.50 0.00 3.16
equal Strides Pharma Science Healthcare 27.57 9.29 3.02 3.02
down Gland Pharma Healthcare 51.77 3.18 0.00 2.99
equal Solara Active Pharma Sciences Healthcare 27.90 2.87 0.55 2.78
equal Apollo Hospitals Healthcare 237.56 3.59 0.00 2.67
equal JB Chemicals & Pharma Healthcare 29.95 2.89 0.00 2.67
down Gufic Biosciences Healthcare 40.95 4.42 1.75 2.42
equal Natco Pharma Healthcare 41.52 3.18 0.00 2.21
equal Fortis Healthcare Healthcare -- 2.17 0.00 2.16
down Sequent Scientific Healthcare 70.18 3.44 1.36 2.04
down Abbott India Healthcare 50.22 7.11 0.00 2.03
down Ajanta Pharma Healthcare 25.97 4.64 0.00 2.02
new Glenmark Pharma. Healthcare 18.98 4.64 0.00 0.94
equal Shreno Construction -- 0.68 0.00 0.35

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-May-2021

Fund Manager

— Tanmaya Desai since 27-Jun-2011

Education: Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).

Experience: Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.

Interviews:


1.09%

Change from previous, NAV as on 11-Jun-2021

Growth: ₹ 230.8341

IDCW: ₹ 145.4134


Investment Strategy

The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 1,000
Lock-in Period Not Applicable
Exit Load 0.5% for redemption within 15 days

Basic Details

Fund House: SBI Mutual Fund
Launch Date: 05-Jul-1999
Return Since Launch: 16.74%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 1,899 Cr (As on 31-May-2021)
Expense: 2.27% (As on 30-Apr-2021)
Risk Grade: --
Return Grade: --
Turnover: 52.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW16-Mar-201814.1000

 30-Jan-201510.0000
 31-Dec-20043.9000
 03-Sep-20043.0000
 19-Sep-20031.2000
Growth03-Sep-20043.0000

 19-Sep-20031.2000

Contact Information

AMC: SBI Funds Management Ltd

Address: 9th Floor-Crescenzo, C-38 & 39- G Block, Bandra-Kurla Complex, Bandra (East) Mumbai - 400051

Phone: 022-61793000 / 1800-425-5425

Fax: 022-22189663

Email: [email protected]

Website: http://www.sbimf.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

Your investment strategy for debt funds after the fiasco

DateFriday, 18-Jun-2021
Time12:30 PM - 01:00 PM